Eagle Pharmaceuticals Inc sell Piper Sandler
Start price
09.08.23
/
50%
€17.90
Target price
09.08.24
-
Performance (%)
-79.55%
End price
10.08.24
€3.66
Summary
This prediction ended on 10.08.24 with a price of €3.66. Piper_Sandler correctly predicted massive losses of -79.55% for Eagle Pharmaceuticals Inc. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Eagle Pharmaceuticals Inc | -12.291% | -12.291% | -77.887% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by Piper_Sandler for this prediction
In the thread Eagle Pharmaceuticals Inc diskutieren
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Ratings data for EGRX provided by MarketBeat
In the thread Trading Eagle Pharmaceuticals Inc
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten